Related Experiment Video
Updated: Apr 20, 2026

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
Published on: July 23, 2016
Ophthalmic patients on antithrombotic drugs: a review and guide to perioperative management
Insights
Managing patients on antiplatelet and anticoagulant drugs undergoing eye surgery is crucial. This review guides optimal drug management to minimize bleeding and clotting risks in ophthalmic procedures.
Area of Science:
- Ophthalmology
- Pharmacology
- Surgical Science
Background:
- Increasing prevalence of antiplatelet and anticoagulant drug use in patients undergoing ophthalmic surgery.
- Growing risk of bleeding complications in this patient population.
Purpose of the Study:
- To review traditional and newer antiplatelet and anticoagulant agents.
- To provide recommendations for managing these medications in ophthalmic surgery.
- To minimize bleeding and thrombotic risks.
Main Methods:
- Literature review of antiplatelet and anticoagulant agents.
- Analysis of drug use in cataract, vitreoretinal, glaucoma, and oculoplastic surgery.
- Development of management guidelines.
Main Results:
- Identification of specific risks associated with various agents.
- Recommendations for continuation, cessation, and re-commencement of medications.
- Strategies to balance bleeding and thrombotic risks.
Conclusions:
- Optimal management of antiplatelet and anticoagulant drugs is essential for patient safety in ophthalmic surgery.
- Evidence-based recommendations aid in minimizing perioperative complications.
- Awareness of drug profiles is key for successful surgical outcomes.
Abstract:
The changing profile of patients undergoing ophthalmic surgery, with an increase in prevalence of antiplatelet and anticoagulant drug use, predisposes to bleeding complications. This mandates an awareness of these agents, allowing optimal patient management. We review traditional and newer agents in the context of cataract, vitreoretinal, glaucoma and oculoplastic surgery. Recommendations are given for continuation, cessation and re-commencement of these agents in order to minimise the risk of bleeding and thrombotic/thromboembolic complications.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Aneurysm IV: Nursing Management
Venous Thrombosis IV: Nursing Management
Peripheral Artery Disease V: Postoperative Nursing Management
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Ophthalmic Drug Delivery Systems

